KERALA AYURVEDA
|
The Current P/E Ratio of KERALA AYURVEDA is 266.67.
Share Price | ₹336.5 | Feb 17,2025 |
Market Cap | ₹403.7 Cr | |
Earnings-TTM | ₹1.5 Cr | TTM-Consolidated Results |
Price/Earnings | 266.67x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of KERALA AYURVEDA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹403.7 Cr] as on Feb 17,2025
(/) Earnings [ ₹1.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 266.67x ]
Thus, for KERALA AYURVEDA , the investors are currently willing to pay 266.67 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KERALA AYURVEDA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of KERALA AYURVEDA over the last five years.
Historical PE (Price/Earnings) ratio chart of KERALA AYURVEDA
PE Ratio Performance Analysis for KERALA AYURVEDA
- KERALA AYURVEDA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 8.97x.
- KERALA AYURVEDA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KERALA AYURVEDA 's p/e ratio peaked in Mar2022 at 34.93x.
- KERALA AYURVEDA 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does KERALA AYURVEDA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
KERALA AYURVEDA | 1.51 | 266.67 | 403.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 35.79 | 411,102.0 |
CIPLA LTD | 5,000.43 | 23.79 | 118,974.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.44 | 100,112.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 20.25 | 92,991.1 |
DIVIS LABORATORIES LTD | 2,067.00 | 76.02 | 157,137.0 |
MANKIND PHARMA LTD | 2,050.73 | 47.20 | 96,786.8 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 55.93 | 104,141.0 |
LUPIN LTD | 2,892.10 | 31.97 | 92,467.1 |
AUROBINDO PHARMA LTD | 3,500.25 | 19.41 | 67,956.7 |
ABBOTT INDIA LTD | 1,334.46 | 45.51 | 60,736.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KERALA AYURVEDA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.44x |
Max industry PE | 266.67x |
Median industry PE | 35.79x |
Average industry PE | 58.27x |
You may also like the below Video Courses